OmniAb (OABI) Total Non-Current Liabilities (2021 - 2026)

OmniAb's (OABI) quarterly Total Non-Current Liabilities came in at $30.9 million in Q1 2026, down 5.06% year-on-year from $32.6 million in Q1 2025, and down 8.52% on a QoQ basis from $33.8 million in Q4 2025.

OmniAb (OABI) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Total Non-Current Liabilities data on file, last reported at $30.9 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 5.06% year-over-year to $30.9 million in Q1 2026; TTM through Mar 2026 was $30.9 million, a 5.06% decrease from a year earlier, with the FY2025 full-year figure at $33.8 million, down 10.69% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $30.9 million, down from $33.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for OABI reached as high as $79.8 million in Q4 2022 and fell as low as $30.9 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $48.3 million across 5 years, with a median of $41.4 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities gained 22.13% in 2022 and plunged 37.5% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $79.8 million in 2022, then decreased by 28.02% to $57.4 million in 2023, then slumped by 34.09% to $37.9 million in 2024, then retreated by 10.69% to $33.8 million in 2025, then dropped by 8.52% to $30.9 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $30.9 million in Q1 2026, $33.8 million in Q4 2025, and $32.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 30.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.93 Mn
Dec 31, 2025 33.81 Mn
Sep 30, 2025 32.17 Mn
Jun 30, 2025 33.53 Mn
Mar 31, 2025 32.58 Mn
Dec 31, 2024 37.85 Mn
Sep 30, 2024 39.77 Mn
Jun 30, 2024 43.03 Mn
Mar 31, 2024 51.13 Mn
Dec 31, 2023 57.44 Mn
Sep 30, 2023 63.64 Mn
Jun 30, 2023 68.05 Mn
Mar 31, 2023 72.20 Mn
Dec 31, 2022 79.79 Mn
Dec 31, 2021 65.33 Mn